Given the role of PCSK9 in mediating LDLR degradation and regulating LDL-C levels, the present study aimed to evaluate PCSK9 concentrations in non-smoking and smoking women with PCOS in the context of excess body weight and insulin resistance. Here, LDLR is linked to polycystic ovary syndrome.